Cargando…
MMP-2 and MMP-9 gene polymorphisms act as biological indicators for ulinastatin efficacy in patients with severe acute pancreatitis
BACKGROUND: Severe acute pancreatitis (SAP) is a severe form of inflammatory disease with a high mortality rate. Ulinastatin, as a urinary trypsin inhibitor (UTI), is a glycoprotein playing a critical role in SAP. Consequently, we identified the hypothesis that both matrix metalloproteinase-2 (MMP-2...
Autores principales: | Ling, Lan, Li, Yan, Li, Hong, Li, Wen, Zhang, Hong-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587626/ https://www.ncbi.nlm.nih.gov/pubmed/31192912 http://dx.doi.org/10.1097/MD.0000000000015831 |
Ejemplares similares
-
Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis
por: Zhen, Guo-Dong, et al.
Publicado: (2017) -
The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis
por: Yan, Yulan, et al.
Publicado: (2014) -
Meta-Analysis of MMP2, MMP3, and MMP9 Promoter Polymorphisms and Head and Neck Cancer Risk
por: Zhang, Caiyun, et al.
Publicado: (2013) -
Efficacy of ulinastatin for the treatment of patients with severe acute pancreatitis
por: Yao, Jian-hui, et al.
Publicado: (2019) -
Effect of Kaempferol on the Biological Behavior of Human Colon Cancer via Regulating MMP1, MMP2, and MMP9
por: Zhang, Xiaoyu, et al.
Publicado: (2022)